Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

44,831 stories, page 626 of 748

Advanced search

🇺🇸Jun 30Researchclinicaltrials.govTier 1 · Trial registry

NCT07570069: Effects of Efavirenz on the Pharmacokinetics of Suzetrigine in Healthy Participants

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jun 30Researchclinicaltrials.govTier 1 · Trial registry

NCT07440225: A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Study type: INTERVENTIONAL. Phase: PHASE2, PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jun 30Researchclinicaltrials.govTier 1 · Trial registry

NCT07279636: A Study to Evaluate Single Doses of Alpha-0261 in Healthy Adult Volunteers

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jun 30Researchclinicaltrials.govTier 1 · Trial registry

NCT07276373: Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jun 30Researchclinicaltrials.govTier 1 · Trial registry

NCT07261033: Exploring Equine-Assisted Psychotherapy as an Intervention for Those Who Have Received a Diagnosis of Emotionally Unstable Personality Disorder

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jun 30Researchclinicaltrials.govTier 1 · Trial registry

NCT07151716: Sedation With Dexmedetomidine-esketamine Combination and Delirium in ICU Patients

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source

🇺🇸Jun 30Researchclinicaltrials.govTier 1 · Trial registry

NCT07087340: Early Feasibility Evaluation of the UniBE Hybrid Closed-loop Insulin Delivery System in Type 1 Diabetes: UBLoop-Genesis

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jun 30Researchclinicaltrials.govTier 1 · Trial registry

NCT06964685: Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jun 30Researchclinicaltrials.govTier 1 · Trial registry

NCT06757868: Amobarbital and Cardiopulmonary Bypass

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jun 30Researchclinicaltrials.govTier 1 · Trial registry

NCT06675864: Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS)

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jun 30Researchclinicaltrials.govTier 1 · Trial registry

NCT06257537: Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jun 30Researchclinicaltrials.govTier 1 · Trial registry

NCT06145009: Time Restricted Eating, Eating Behaviors, and Cardiometabolic Risk in Emerging Adult Women

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jun 30Researchclinicaltrials.govTier 1 · Trial registry

NCT05958771: The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jun 30Researchclinicaltrials.govTier 1 · Trial registry

NCT05714098: Gerofit Exercise Intervention for Older Adults With Sickle Cell Disease (SICKLE-FIT Study)

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jun 30Researchclinicaltrials.govTier 1 · Trial registry

NCT05541783: Laparoscopic-assisted Distal Gastrectomy and Totally Laparoscopic Distal Gastrectomy for Gastric Cancer

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jun 30Researchclinicaltrials.govTier 1 · Trial registry

NCT05170958: A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jun 30Researchclinicaltrials.govTier 1 · Trial registry

NCT04887935: Neoadjuvant SGLT2 Inhibition in Localized Prostate Cancer

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jun 30Researchclinicaltrials.govTier 1 · Trial registry

NCT04847258: Rate of Non-copers to Non-surgical ACL Treatment After 3 Months of Rehabilitation

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jun 30Researchclinicaltrials.govTier 1 · Trial registry

NCT03937830: Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jun 30Researchclinicaltrials.govTier 1 · Trial registry

NCT02516423: Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jun 30Researchclinicaltrials.govTier 1 · Trial registry

NCT00006518: Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jun 30Researchclinicaltrials.govTier 1 · Trial registry

NCT00001486: Genetic Study of Schizophrenia

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Youngshin Kwak, Head of Oscotec Research Institute: "We Will Compete with Anti-Resistance Cancer Therapy Within 3 Years" [BioUSA]

아시아경제Original source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.

PBSOriginal source

🌍Jun 30Mediaechonous.comTier 2 · Direct publisher

Advancing Perioperative Ultrasound: Dr. Deepak Borde on AI and Echoliteracy

EchoNousOriginal source

🇺🇰Jun 30Regulatorygov.ukTier 1 · Regulatory source

UK’s first maternity and neonatal commissioner to be appointed

New commissioner and extra funding announced to make maternity and neonatal care safer, fairer and m...

UK Department of Health and Social CareOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Cellid Crashes After-Hours on Phase 3 Failure...Shaperon Dives 25%[K-bio pulse]

이데일리Original source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

French biotech company Ipsen to buy Kartos Therapeutics for $450 million

ReutersOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Biotech Is The Rate Cut Trade In Disguise

Seeking AlphaOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Abivax reports phase 3 ulcerative colitis trial results

Investing.com UKOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

FDA extends Praxis (NASDAQ: PRAX) relutrigine review deadline to Dec 27, 2026

Stock TitanOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request

The Manila TimesOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Suspends Licences Of 6 Mumbai Eateries Over Rat Infestation, Expired Food, And Unhygienic

Free Press JournalOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

FDA’s Drug Repurposing Initiative Signals a Shift in Regulatory Strategy

JD SupraOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

PBM lobby goes on the offensive

The HillOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

The EU’s Biotech Act (Part 2): compelling changes to clinical trial regulation

IQVIAOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Silo Pharma tests nasal spray device for PTSD drug ahead of FDA meeting

Stock TitanOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Silo Pharma Advances SPC-15 PTSD Therapeutic with

GlobeNewswireOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Abivax’s ulcerative colitis drug shows benefit in hard-to-treat patients

Stock TitanOriginal source

🌍Jun 30discoverynews.google.comTier 2 · Trade media

Ipsen’s $450M Deal Brings Drug That Could Make a Standard Blood Cancer Therapy Better

MedCity NewsOriginal source

🇺🇰Jun 30Regulatorygov.ukTier 1 · Regulatory source

Resident doctors agree deal with government to end strikes

BMA votes to accept offer that will see resident doctors benefit from new pay structure and better c...

UK Department of Health and Social CareOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Vancouver biotech Zymeworks buying Theravance for US$929M

Business in VancouverOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

DEA And FDA Highlight How Marijuana Is Safer Than Alcohol And Opioids During Rescheduling Hearing's Opening Day

Marijuana MomentOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Gerren McHam: What Effective Pharma Reshoring Actually Requires

Pharmaceutical CommerceOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

UNCY Stock Rallies 8% As Retail Traders Anticipate FDA Clearance For Lead Drug Candidate

TradingViewOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Ipsen Enters Merger Agreement to Acquire Kartos Therapeutics | PharmExec

Pharmaceutical ExecutiveOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Sagimet Biosciences added to Russell 2000 and 3000 indexes

Investing.com UKOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

COMP360, REMS and What FDA Psychedelic Approval Path Means for Investors and Operators

JD SupraOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Pediatric clinical trial update: Q2 2026

Contemporary PediatricsOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Maharashtra Orders Statewide Blood Bank Inspection Drive After FDA Crackdown On Safety Violations

Free Press JournalOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

The Biotech Winter Finally Thaws

Brownstone ResearchOriginal source

🌍Jun 30discoverynews.google.comTier 2 · Trade media

FDA issues complete response letter to Sobi’s NASP for gout

Pharmaceutical TechnologyOriginal source

🌍Jun 30discoverynews.google.comTier 2 · Trade media

Lilly’s Jaypirca receives CHMP positive opinion for CLL in Europe

Pharmaceutical TechnologyOriginal source

🇪🇺Jun 30Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106

CORDISOriginal source

🇪🇺Jun 30Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: SInGle cells iN AuToimmUne inflammatoRy disEases

CORDISOriginal source

🇪🇺Jun 30Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Targeting Circadian Clock Dysfunction in Alzheimer’s Disease

CORDISOriginal source

🇪🇺Jun 30Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Doctoral network for microprocess engineering for electrosynthesis - new synthesis concepts for pharmaceutical/ fine chemical industry

CORDISOriginal source

🇪🇺Jun 30Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: NEXT GENERATION VACCINES AGAINST GASTROINTESTINAL MUCOSAL PATHOGENS, USING HELICOBACTER PYLORI AS MODEL PATHOGEN

CORDISOriginal source

🇪🇺Jun 30Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Immunopeptidomics-based Development of Next-Generation Bacterial mRNA Vaccines

CORDISOriginal source

🌍Jun 30discoverynews.google.comTier 3 · Aggregated media

Why I’m Eyeing Prices, Biotech and AI in Q3

TheStreet ProOriginal source